<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04310683</url>
  </required_header>
  <id_info>
    <org_study_id>PREECLAMPSIA</org_study_id>
    <nct_id>NCT04310683</nct_id>
  </id_info>
  <brief_title>Natural Cycle or Stimulated Cycle Versus Hormone Replaced Cycle for Pre-eclampsia Rate</brief_title>
  <official_title>The Live Birth Rate in Natural Cycle or Stimulated Cycle Versus Hormone Replaced Cycle in Patients Undergoing Frozen-thawed Embryo Transfer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Women's Hospital School Of Medicine Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Women's Hospital School Of Medicine Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent sutdies indicate that the existence of corpus lutein in the ovary is a key point to
      prevent preeclampsia, and patients undergoing FET with hormone replaced cycle have no corpus
      lutein and the absence of corpus lutein significantly increases the risk of preeclampsia in
      these patients. We aim to conduct a single center randomized trial study to compare the
      preeclampsia rate between the natural cycle and the hormone replaced cycle in patients
      undergoing FET.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 10, 2020</start_date>
  <completion_date type="Anticipated">March 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>live birth rate</measure>
    <time_frame>delivery</time_frame>
    <description>A delivery is considered successful live birth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pre-eclampsia</measure>
    <time_frame>From gestational week 20 to delivery</time_frame>
    <description>Preeclampsia is defined using the current American College of Obstetricians and Gynecologists definitions (Gynecologists; and Pregnancy 2013)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">840</enrollment>
  <condition>Pre-Eclampsia</condition>
  <arm_group>
    <arm_group_label>natural cycle for endometrium preparation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients will have ovulation before embryo transfer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hormone replaced cycle for endometrium preparation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will do not have ovulation before embryo transfer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>natural cycle for endometrium preparation</intervention_name>
    <description>patients will not use oral contraceptive drugs</description>
    <arm_group_label>natural cycle for endometrium preparation</arm_group_label>
    <other_name>non</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hormone replaced cycle for endometrium preparation</intervention_name>
    <description>patients will receive oral contraceptive drugs for menstruation before embryo transfer</description>
    <arm_group_label>hormone replaced cycle for endometrium preparation</arm_group_label>
    <other_name>non</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 to 42 years old women;

          2. normal ovulation;

          3. Scheduled to undergo frozen-thawed embryo transfer.

          4. Agreeing with the informed consent.

        Exclusion Criteria:

          1. Those who experienced embryo transfer cycle failure for at least three times;

          2. One or both of the ovaries removed;

          3. Hypertention disease before embryo transfer;

          4. No available embryo for transfer

          5. Oocyte or sperm donated cycles
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Zhang, M.D. Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Women's Hospital School Of Medicine Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dan Zhang, M.D. Ph.D.</last_name>
    <phone>86-0571-87061501-1008</phone>
    <email>zhangdan@zju.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kai-Lun Hu, M.D.</last_name>
    <phone>86-010-15901575271</phone>
    <email>hukailun@bjmu.edu.cn</email>
  </overall_contact_backup>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 14, 2020</study_first_submitted>
  <study_first_submitted_qc>March 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 14, 2020</last_update_submitted>
  <last_update_submitted_qc>March 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

